GSK Gsk Plc

TIDMGSK

RNS Number : 2251L

GlaxoSmithKline PLC

04 September 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                    Mrs V A Whyte 
====  =======================================  ================================================== 
 b)    Position/status                         SVP & Company Secretary 
====  =======================================  ================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument 
                                                ISIN: GB0009252882 
====  =======================================  ================================================== 
 b)    Nature of the                           Award of Ordinary Shares under the Company's 
        transaction                             2009 Share Value Plan 
====  =======================================  ================================================== 
 c)    Price(s) and                             Price(s)                  Volume(s) 
        volume(s) 
====  =======================================   ========================  ===================== 
   GBP17.434                                                              10,050 
   =====================================================================  ===================== 
 
 d)    Aggregated information                  N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ============================ 
 e)    Date of the transaction                 2019-09-03 
====  =======================================  ================================================== 
 f)    Place of the                            N/A 
        transaction 
====  =======================================  ================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFZLFBKKFXBBX

(END) Dow Jones Newswires

September 04, 2019 07:36 ET (11:36 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024